Resverlogix (RVXCF, $0.03) was a top loser over the last three months, falling to $0.03 per share. A.I.dvisor analyzed 849 stocks in the Biotechnology Industry for the 3-month period ending April 7, 2025, and found that of them () exhibited an Uptrend while of them () demonstrated a Downtrend.